Related Experiment Video
Updated: May 28, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier
Kohei Okuyama1, Maiko Tsuchiya2, Kala Chand Debnath3
1Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 123, Houston, TX 77030-4009, USA.
Abstract:
Head and neck squamous cell carcinoma (HNSCC) remains a challenge due to limited prognostic biomarkers and therapeutic options. The tumor microenvironment (TME), particularly the desmoplastic reaction (DR) characterized by stromal fibrosis, plays a crucial role in cancer progression and resistance to therapy. This review aims to summarize the biological significance of DR in HNSCC initiation, progression, and treatment resistance. Histologically, DR in HNSCC correlates with invasion patterns and clinical outcomes, affecting disease-free and overall survival. The interaction between cancer-associated fibroblasts (CAFs) and TME influences immune responses, including resistance to immunotherapy. Notably, human papillomavirus-driven HNSCC exhibits distinct DR characteristics that further influence the prognosis. DR promotes epithelial-mesenchymal transition and cancer cell invasion through CAF-mediated extracellular matrix remodeling and signaling pathways such as transforming growth factor-beta. DR also affects bone invasion and chemotherapy resistance by modulating stromal responses. Therapeutic strategies targeting DR and stromal components show promise in overcoming therapeutic resistance including resistance to immune checkpoint inhibitors. Understanding the role of DR in HNSCC biology and its impact on treatment response is critical to developing effective therapeutic interventions.
Insights
The desmoplastic reaction (DR) in head and neck squamous cell carcinoma (HNSCC) promotes cancer progression and treatment resistance. Targeting DR and its associated stromal components offers promising therapeutic strategies for HNSCC.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Head and neck squamous cell carcinoma (HNSCC) presents significant challenges due to a lack of effective prognostic biomarkers and therapies.
- The tumor microenvironment (TME), specifically the desmoplastic reaction (DR) involving stromal fibrosis, is increasingly recognized for its role in HNSCC progression and therapeutic resistance.
Purpose of the Study:
- To review the biological significance of the desmoplastic reaction (DR) in the initiation, progression, and treatment resistance of HNSCC.
- To explore the impact of DR on clinical outcomes, immune responses, and therapeutic strategies in HNSCC.
Main Methods:
- Literature review synthesizing existing research on the desmoplastic reaction in HNSCC.
- Analysis of histological correlations between DR, invasion patterns, and patient survival.
- Examination of the role of cancer-associated fibroblasts (CAFs) and extracellular matrix remodeling in DR-mediated effects.
Main Results:
- DR in HNSCC is linked to specific invasion patterns and negatively impacts disease-free and overall survival.
- CAFs within the TME contribute to immune evasion and resistance to immunotherapy.
- DR influences epithelial-mesenchymal transition, bone invasion, and chemotherapy resistance via CAF signaling pathways.
Conclusions:
- The desmoplastic reaction is a critical factor in HNSCC progression and resistance to various therapies, including immunotherapy.
- Distinct DR characteristics in human papillomavirus-driven HNSCC influence prognosis.
- Targeting DR and stromal interactions presents a viable strategy to enhance therapeutic efficacy in HNSCC.
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...

